Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)

0.8866
Delayed Data
As of Sep 23
 -0.0449 / -4.82%
Today’s Change
0.84
Today|||52-Week Range
4.63
-69.22%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Zynerba Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 11.00 and a low estimate of 1.00. The median estimate represents a +689.53% increase from the last price of 0.89.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Zynerba Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.23
Sales
$0.00
Reporting Date
Nov 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.83%
 
 
 
 
 
 
Growthannually 5.47%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.